SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 8.36 |
| Enterprise Value ($M) | 3.71 |
| Book Value ($M) | 2.31 |
| Book Value / Share | 0.10 |
| Price / Book | 3.61 |
| NCAV ($M) | 2.31 |
| NCAV / Share | 0.10 |
| Price / NCAV | 3.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -5.14 |
| Return on Assets (ROA) | -1.30 |
| Return on Equity (ROE) | -1.98 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.93 |
| Current Ratio | 1.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.81 |
| Assets | 4.81 |
| Liabilities | 2.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -14.10 |
| Net Income | -14.10 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -10.38 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.62 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 48,994 | 135,089 | 36.27 | |
| 49,488 | 117,006 | 42.30 | |
| 52,936 | 190,927 | 27.73 | |
| 271,697 | 643,399 | 42.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABVC – ABVC BioPharma, Inc. | ACB – Aurora Cannabis Inc. |
| ACHV – Achieve Life Sciences, Inc. | ADIL – Adial Pharmaceuticals, Inc. |
| ADTX – Aditxt, Inc. |
Financial data and stock pages provided by
Fintel.io